Almanack Investment Partners’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,667
Closed -$208K 974
2022
Q2
$208K Sell
2,667
-81
-3% -$6.69K 0.02% 400
2022
Q1
$234K Sell
2,748
-87
-3% -$8.34K 0.02% 412
2021
Q4
$340K Sell
2,835
-9
-0.3% -$1.12K 0.03% 347
2021
Q3
$352K Buy
2,844
+63
+2% +$8.11K 0.03% 336
2021
Q2
$334K Buy
2,781
+94
+3% +$10.7K 0.03% 301
2021
Q1
$283K Sell
2,687
-132
-5% -$13.4K 0.03% 324
2020
Q4
$287K Buy
2,819
+48
+2% +$4.51K 0.03% 293
2020
Q3
$264K Sell
2,771
-558
-17% -$43.4K 0.03% 319
2020
Q2
$216K Buy
+3,329
New +$220K 0.04% 226

Other funds holding XYL

Almanack Investment Partners's XYL Position: Q3 2022 in Review

Almanack Investment Partners sold out of Xylem (XYL) in Q3 2022, closing a stake of 2,667 shares — an estimated $208K sold.

Almanack Investment Partners first reported a position in XYL in Q2 2020 and held it in 9 quarters. The position peaked at $352K in Q3 2021. 740 funds tracked by Wall St. Rank hold XYL as of Q3 2022.

  • Almanack Investment Partners reported no remaining Xylem position as of Q3 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 2,667 Xylem shares in Q3 2022, an estimated $208K.
  • Almanack Investment Partners first reported a position in Xylem in Q2 2020 and held it in 9 quarters.
  • Almanack Investment Partners's Xylem position peaked at $352K in Q3 2021.
  • 740 funds tracked by Wall St. Rank held Xylem as of Q3 2022.

Based on Almanack Investment Partners's 13F filing for Q3 2022, filed 15 Nov 2022.